| Style | Citing Format |
|---|---|
| MLA | Athari SS, et al.. "Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism." Mitochondrial Signaling and Regulation: Immune Responses and Diseases, vol. , no. , 2025, pp. 363-530. |
| APA | Athari SS, Nasab EM, Rajjoub RA, Soor TAH, Rashan L, Borji M, Changez M, Hajimohammadi B, Abdalla Y (2025). Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism. Mitochondrial Signaling and Regulation: Immune Responses and Diseases, (), 363-530. |
| Chicago | Athari SS, Nasab EM, Rajjoub RA, Soor TAH, Rashan L, Borji M, Changez M, Hajimohammadi B, Abdalla Y. "Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism." Mitochondrial Signaling and Regulation: Immune Responses and Diseases , no. (2025): 363-530. |
| Harvard | Athari SS et al. (2025) 'Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism', Mitochondrial Signaling and Regulation: Immune Responses and Diseases, (), pp. 363-530. |
| Vancouver | Athari SS, Nasab EM, Rajjoub RA, Soor TAH, Rashan L, Borji M, et al.. Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism. Mitochondrial Signaling and Regulation: Immune Responses and Diseases. 2025;():363-530. |
| BibTex | @article{ author = {Athari SS and Nasab EM and Rajjoub RA and Soor TAH and Rashan L and Borji M and Changez M and Hajimohammadi B and Abdalla Y}, title = {Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism}, journal = {Mitochondrial Signaling and Regulation: Immune Responses and Diseases}, volume = {}, number = {}, pages = {363-530}, year = {2025} } |
| RIS | TY - JOUR AU - Athari SS AU - Nasab EM AU - Rajjoub RA AU - Soor TAH AU - Rashan L AU - Borji M AU - Changez M AU - Hajimohammadi B AU - Abdalla Y TI - Mitochondria in Immune Cells: Their Role in Immunity, Inflammation, and Metabolism JO - Mitochondrial Signaling and Regulation: Immune Responses and Diseases VL - IS - SP - 363 EP - 530 PY - 2025 ER - |